Variant position: 440 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 638 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human EADLLCLDQKNQNNSPYHDA CPATQQPSVIQAEKN-KPQPLP
Rhesus macaque EADLLCLDQKNQNKSPYHDA CPATQQPSVIQAEKN-KPQPL
Mouse EADLLCLDQKNLKNLPY-DA SLGSLHPSITQTVEENKPQPL
Rat EADLLCLDQKNLKNSPY-DA SLGSLHPSITLTMED-KPQPL
Pig EADLLCLDQKNQNNSPSNDA APATQQPSVILAEEN-KPRPL
Bovine EADISCLDQKNQNNSPSNDA APASQQPSVILVEEN-KPRPL
Rabbit EADLLCLDQKNQNNSPYHDV SPAAQQPEVVLAEED-KPRPL
Sheep EADILCLDQKNQNNSPSNDA APASQQPSVILVEEN-KPRPL
Chicken EEDLLCLHRKDDVEALQSLA NTDTQQPHTSTQSESRESWPP
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
19 – 638 Growth hormone receptor
289 – 638 Cytoplasmic
295 – 638 Missing. In isoform 3.
298 – 638 Missing. In isoform 2.
Amino acid substitutions in the intracellular part of the growth hormone receptor in a patient with the Laron syndrome.
Kou K.; Lajara R.; Rotwein P.;
J. Clin. Endocrinol. Metab. 76:54-59(1993)
Cited for: VARIANT PHE-440;
Characterization of single-nucleotide polymorphisms in coding regions of human genes.
Cargill M.; Altshuler D.; Ireland J.; Sklar P.; Ardlie K.; Patil N.; Shaw N.; Lane C.R.; Lim E.P.; Kalyanaraman N.; Nemesh J.; Ziaugra L.; Friedland L.; Rolfe A.; Warrington J.; Lipshutz R.; Daley G.Q.; Lander E.S.;
Nat. Genet. 22:231-238(1999)
Cited for: VARIANTS HIS-179; HIS-229; PHE-440; THR-495; LEU-544 AND THR-579;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.